Cargando…
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignanc...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825013/ https://www.ncbi.nlm.nih.gov/pubmed/31487418 http://dx.doi.org/10.1111/cas.14190 |
_version_ | 1783464827183693824 |
---|---|
author | Gao, Yuan Wang, Zheng Zhu, Yidi Zhu, Qin Yang, Yang Jin, Yunpeng Zhang, Fei Jiang, Lin Ye, Yuanyuan Li, Huaifeng Zhang, Yichi Liang, Haibin Xiang, Shanshan Miao, Huijie Liu, Yingbin Hao, Yajuan |
author_facet | Gao, Yuan Wang, Zheng Zhu, Yidi Zhu, Qin Yang, Yang Jin, Yunpeng Zhang, Fei Jiang, Lin Ye, Yuanyuan Li, Huaifeng Zhang, Yichi Liang, Haibin Xiang, Shanshan Miao, Huijie Liu, Yingbin Hao, Yajuan |
author_sort | Gao, Yuan |
collection | PubMed |
description | NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignancy and has a poor prognosis, remains to be determined. Here we found that NSUN2 was highly expressed in GBC tissues as well as cell lines. NSUN2 silencing repressed GBC cell proliferation and tumorigenesis both in vitro and in vivo. Conversely, upregulation of NSUN2 enhanced GBC cell growth and colony formation. We further discovered that RPL6 was a closely interacting partner with NSUN2. Silencing RPL6 resulted in insufficient NSUN2 translational level and accumulative NSUN2 transcriptional level. Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression. Taken together, our data provided novel mechanic insights into the function of NSUN2 in GBC, thus pointing to NSUN2 as a potential and effective therapeutic approach to GBC treatment. |
format | Online Article Text |
id | pubmed-6825013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68250132019-11-07 NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma Gao, Yuan Wang, Zheng Zhu, Yidi Zhu, Qin Yang, Yang Jin, Yunpeng Zhang, Fei Jiang, Lin Ye, Yuanyuan Li, Huaifeng Zhang, Yichi Liang, Haibin Xiang, Shanshan Miao, Huijie Liu, Yingbin Hao, Yajuan Cancer Sci Original Articles NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignancy and has a poor prognosis, remains to be determined. Here we found that NSUN2 was highly expressed in GBC tissues as well as cell lines. NSUN2 silencing repressed GBC cell proliferation and tumorigenesis both in vitro and in vivo. Conversely, upregulation of NSUN2 enhanced GBC cell growth and colony formation. We further discovered that RPL6 was a closely interacting partner with NSUN2. Silencing RPL6 resulted in insufficient NSUN2 translational level and accumulative NSUN2 transcriptional level. Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression. Taken together, our data provided novel mechanic insights into the function of NSUN2 in GBC, thus pointing to NSUN2 as a potential and effective therapeutic approach to GBC treatment. John Wiley and Sons Inc. 2019-09-23 2019-11 /pmc/articles/PMC6825013/ /pubmed/31487418 http://dx.doi.org/10.1111/cas.14190 Text en © 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Gao, Yuan Wang, Zheng Zhu, Yidi Zhu, Qin Yang, Yang Jin, Yunpeng Zhang, Fei Jiang, Lin Ye, Yuanyuan Li, Huaifeng Zhang, Yichi Liang, Haibin Xiang, Shanshan Miao, Huijie Liu, Yingbin Hao, Yajuan NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title |
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title_full |
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title_fullStr |
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title_full_unstemmed |
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title_short |
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma |
title_sort | nop2/sun rna methyltransferase 2 promotes tumor progression via its interacting partner rpl6 in gallbladder carcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825013/ https://www.ncbi.nlm.nih.gov/pubmed/31487418 http://dx.doi.org/10.1111/cas.14190 |
work_keys_str_mv | AT gaoyuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT wangzheng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT zhuyidi nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT zhuqin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT yangyang nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT jinyunpeng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT zhangfei nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT jianglin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT yeyuanyuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT lihuaifeng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT zhangyichi nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT lianghaibin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT xiangshanshan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT miaohuijie nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT liuyingbin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma AT haoyajuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma |